Real-Time Quote
 +0.36 / +0.61%
Today’s Change
Today|||52-Week Range
The Biggest Biotech Wins of the Week
Apr 15 / MotleyFool.com
Takeda: a fine mess
Apr 08 / FT.com
Eli Lilly/ Boehringer Drug Under FDA Review - Analyst Blog
Apr 15 / Zacks.com
5 Stocks Forging the Future of Breast Cancer Care
Apr 08 / MotleyFool.com
Eli Lilly's $3 Billion Mistake
Apr 14 / MotleyFool.com
Todaybs Top Biotech Stories: Takeda, Eli Lilly, Immunomedics, and Pharmacyclics
Apr 08 / MotleyFool.com
MannKind's Overly-Optimisitic Investors
Apr 14 / MotleyFool.com
Takeda ordered to pay $6bn over diabetes drug claims
Apr 08 / FT.com
Market Wrap For April 14: Markets Surge on Positive Retail Data, Citi Earnings
Apr 14 / Benzinga
Pfizer Inc's Palbociclib Delivers the Goods
Apr 07 / MotleyFool.com
Is Teva Pharmaceutical Industries Ltd. Destined for Greatness?
Apr 14 / MotleyFool.com
3 Reasons an Ariad Pharmaceuticals Buyout Is Unlikely
Apr 04 / MotleyFool.com
Can This Drug Be a Game Changer for Eli Lilly?
Apr 11 / MotleyFool.com
Tech industry has opened a Pandora's box of patent strife
Apr 03 / FT.com
Three Dividend Stocks in Bullish Trends
Apr 11 / TheStreet.com
Eli Lilly Signs Deal with Prasco - Analyst Blog
Apr 02 / Zacks.com
2 Biotech Stocks to Watch: Merrimack Pharmaceuticals and Sunesis Pharmaceuticals
Apr 10 / MotleyFool.com
Positive Panel, but 3 Risks Remain for MannKind Corporation
Apr 02 / MotleyFool.com
3 Stocks Near 52-Week Highs Worth Selling
Apr 10 / MotleyFool.com
Is an Ariad Pharmaceuticals, Inc. Acquisition Realistic?
Apr 02 / MotleyFool.com
3 Breast Cancer Drugs With Big Potential
Apr 10 / MotleyFool.com
Whatbs Next for MannKind Corp.?
Apr 02 / MotleyFool.com
Next-Gen Breast Cancer Drugs Offer Patients Hope
Apr 09 / MotleyFool.com
Big pharma's rise in China not held back by scandals
Apr 01 / FT.com
Takeda and Eli Lilly fall foul of jury in Actos trial
Apr 08 / FT.com
Viagra scientist chases new sexual health breakthrough
Mar 17 / FT.com

To view my watchlist

Not a member yet?

Sign up now for a free account
Market indexes are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET. Disclaimer LIBOR Warning: Neither BBA Enterprises Limited, nor the BBA LIBOR Contributor Banks, nor Reuters, can be held liable for any irregularity or inaccuracy of BBA LIBOR. Disclaimer. Morningstar: © 2014 Morningstar, Inc. All Rights Reserved. Disclaimer The Dow Jones IndexesSM are proprietary to and distributed by Dow Jones & Company, Inc. and have been licensed for use. All content of the Dow Jones IndexesSM © 2014 is proprietary to Dow Jones & Company, Inc. Chicago Mercantile Association. The market data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved. FactSet Research Systems Inc. 2014. All rights reserved. Most stock quote data provided by BATS.